Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Resetting the transcription factor network reverses terminal chronic hepatic failure
Taichiro Nishikawa, … , Alejandro Soto-Gutierrez, Ira J. Fox
Taichiro Nishikawa, … , Alejandro Soto-Gutierrez, Ira J. Fox
Published March 16, 2015
Citation Information: J Clin Invest. 2015;125(4):1533-1544. https://doi.org/10.1172/JCI73137.
View: Text | PDF
Research Article Hepatology Article has an altmetric score of 35

Resetting the transcription factor network reverses terminal chronic hepatic failure

  • Text
  • PDF
Abstract

The cause of organ failure is enigmatic for many degenerative diseases, including end-stage liver disease. Here, using a CCl4-induced rat model of irreversible and fatal hepatic failure, which also exhibits terminal changes in the extracellular matrix, we demonstrated that chronic injury stably reprograms the critical balance of transcription factors and that diseased and dedifferentiated cells can be returned to normal function by re-expression of critical transcription factors, a process similar to the type of reprogramming that induces somatic cells to become pluripotent or to change their cell lineage. Forced re-expression of the transcription factor HNF4α induced expression of the other hepatocyte-expressed transcription factors; restored functionality in terminally diseased hepatocytes isolated from CCl4-treated rats; and rapidly reversed fatal liver failure in CCl4-treated animals by restoring diseased hepatocytes rather than replacing them with new hepatocytes or stem cells. Together, the results of our study indicate that disruption of the transcription factor network and cellular dedifferentiation likely mediate terminal liver failure and suggest reinstatement of this network has therapeutic potential for correcting organ failure without cell replacement.

Authors

Taichiro Nishikawa, Aaron Bell, Jenna M. Brooks, Kentaro Setoyama, Marta Melis, Bing Han, Ken Fukumitsu, Kan Handa, Jianmin Tian, Klaus H. Kaestner, Yoram Vodovotz, Joseph Locker, Alejandro Soto-Gutierrez, Ira J. Fox

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 Total
Citations: 3 6 8 10 9 8 6 5 5 7 3 70
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (70)

Title and authors Publication Year
Perspectives and Tools in Liver Graft Assessment: A Transformative Era in Liver Transplantation
Safi K, Pawlicka AJ, Pradhan B, Sobieraj J, Zhylko A, Struga M, Grąt M, Chrzanowska A
Biomedicines 2025
Hepatic stellate cells: balancing homeostasis, hepatoprotection and fibrogenesis in health and disease.
Schwabe RF, Brenner DA
Nature reviews. Gastroenterology & hepatology 2025
Hepatocyte Nuclear Factor 4 Alpha: A Key Regulator of Liver Disease Pathology and Haemostatic Disorders.
Choudhuri S, Garg NJ
Liver international : official journal of the International Association for the Study of the Liver 2025
Antagonizing Activin A/p15(INK4b) Signaling as Therapeutic Strategy for Liver Disease.
Mekala S, Rai R, Reed SL, Bowen B, Michalopoulos GK, Locker J, Raeman R, Oertel M
Cells 2024
Emerging Roles of RNA-Binding Proteins in Fatty Liver Disease
Adesanya O, Das D, Kalsotra A
Wiley interdisciplinary reviews. RNA 2024
Epithelial-mesenchymal transition in tissue repair and degeneration.
Youssef KK, Nieto MA
Nature reviews. Molecular cell biology 2024
Downregulation of HNF4A enables transcriptomic reprogramming during the hepatic acute-phase response.
Ehle C, Iyer-Bierhoff A, Wu Y, Xing S, Kiehntopf M, Mosig AS, Godmann M, Heinzel T
Communications biology 2024
Transcriptional Control: A Directional Sign at the Crossroads of Adult Hepatic Progenitor Cells' Fates
Xu C, Fang X, Song Y, Xiang Z, Xu X, Wei X
International journal of biological sciences 2024
Hypoxia-Inducible Factor-2α Promotes Liver Fibrosis by Inducing Hepatocellular Death
Mooli RG, Mukhi D, Watt M, Nagati V, Reed SM, Gandhi NK, Oertel M, Ramakrishnan SK
International Journal of Molecular Sciences 2024
Recent Advances in Site-Specific Lipid Nanoparticles for mRNA Delivery
Xu X, Xia T
2023
PPARγ-dependent hepatic macrophage switching acts as a central hub for hUCMSC-mediated alleviation of decompensated liver cirrhosis in rats.
Yao Y, Zhang L, Cheng F, Jiang Q, Ye Y, Ren Y, He Y, Su D, Cheng L, Shi G, Dai L, Deng H
Stem Cell Research & Therapy 2023
An extended transcription factor regulatory network controls hepatocyte identity
Dubois\u2010Chevalier J, Gheeraert C, Berthier A, Boulet C, Dubois V, Guille L, Fourcot M, Marot G, Gauthier K, Dubuquoy L, Staels B, Lefebvre P, Eeckhoute J
EMBO reports 2023
Chemically induced revitalization of damaged hepatocytes for regenerative liver repair
Lin P, Bai Y, Nian X, Chi J, Chen T, Zhang J, Zhang W, Zhou B, Liu Y, Zhao Y
iScience 2023
VEGFA mRNA-LNP promotes biliary epithelial cell-to-hepatocyte conversion in acute and chronic liver diseases and reverses steatosis and fibrosis
Rizvi F, Lee YR, Diaz-Aragon R, Bawa PS, So J, Florentino RM, Wu S, Sarjoo A, Truong E, Smith AR, Wang F, Everton E, Ostrowska A, Jung K, Tam Y, Muramatsu H, Pardi N, Weissman D, Soto-Gutierrez A, Shin D, Gouon-Evans V
Cell Stem Cell 2023
Mechanism and Effect of HNF4α Decrease in a Rat Model of Cirrhosis and Liver Failure
Melis M, Marino R, Tian J, Johnson C, Sethi R, Oertel M, Fox IJ, Locker J
Cellular and Molecular Gastroenterology and Hepatology 2023
Modulation of Hepatocyte Nuclear Factor 4 Alpha (HNF4α): A Critical Mechanism of Disease Progression in Liver Cirrhosis
Apte U
Cellular and Molecular Gastroenterology and Hepatology 2023
HNF4α in Hepatocyte Health and Disease.
Kotulkar M, Robarts DR, Apte U
Seminars in liver disease 2023
Cell-Type Resolved Insights into the Cis-Regulatory Genome of NAFLD
T Dam, N Toft, L Grøntved
Cells 2022
Synergistic and Detrimental Effects of Alcohol Intake on Progression of Liver Steatosis
A Ciaula, L Bonfrate, M Krawczyk, G Frühbeck, P Portincasa
International journal of molecular sciences 2022
Transplantation of bioengineered liver capable of extended function in a preclinical liver failure model
H Higashi, H Yagi, K Kuroda, K Tajima, H Kojima, K Nishi, T Morisaku, K Hirukawa, K Fukuda, K Matsubara, M Kitago, M Shinoda, H Obara, S Adachi, K Nishimura, T Natsume, M Tomi, A SotoGutierrez, Y Kitagawa
American Journal of Transplantation 2022
Therapeutic Potential of HNF4α in End-stage Liver Disease
Diaz-Aragon R, Coard MC, Amirneni S, Faccioli L, Haep N, Malizio MR, Motomura T, Kocas-Kilicarslan ZN, Ostrowska A, Florentino RM, Frau C
Organogenesis 2022
Hepatocyte nuclear factor 4α in the pathogenesis of non-alcoholic fatty liver disease
Pan X, Zhang Y
Chinese Medical Journal 2022
Deriving time-concordant event cascades from gene expression data: A case study for Drug-Induced Liver Injury (DILI).
Liu A, Han N, Munoz-Muriedas J, Bender A
PLoS computational biology 2022
Progressive loss of HNF4α activity in chronic liver diseases in humans
Gunewardena S, Huck I, Walesky C, Robarts D, Weinman S, Apte U
Hepatology 2022
Hepatocyte β-catenin loss is compensated by Insulin-mTORC1 activation to promote liver regeneration.
Hu S, Cao C, Poddar M, Delgado E, Singh S, Singh-Varma A, Stolz DB, Bell A, Monga SP
Hepatology 2022
Multiple Facets of Cellular Homeostasis and Regeneration of the Mammalian Liver
Huppert SS, Schwartz RE
Annual Review of Physiology 2022
Transcription networks in liver development and acute liver failure
Feng R, Liebe R, Weng HL
Liver Research 2022
SMN Depleted Mice Offer a Robust and Rapid Onset Model of Nonalcoholic Fatty Liver Disease
MO Deguise, C Pileggi, YD Repentigny, A Beauvais, A Tierney, L Chehade, J Michaud, M Llavero-Hurtado, D Lamont, A Atrih, TM Wishart, TH Gillingwater, BL Schneider, ME Harper, SH Parson, R Kothary
CMGH Cellular and Molecular Gastroenterology and Hepatology 2021
The Inside-Out of End-Stage Liver Disease: Hepatocytes are the Keystone
N Haep, RM Florentino, JE Squires, A Bell, A Soto-Gutierrez
Seminars in liver disease 2021
Serum transferrin as a biomarker of hepatocyte nuclear factor 4 alpha activity and hepatocyte function in liver diseases
N Guldiken, J Argemi, B Gurbuz, SR Atkinson, M Oliverius, P Fila, K Hamesch, T Bruns, J Cabezas, JJ Lozano, J Mann, S Cao, P Mathurin, VH Shah, C Trautwein, MR Thursz, R Bataller, P Strnad
BMC Medicine 2021
Dual β-catenin and γ-catenin loss in hepatocytes impacts their polarity through altered transforming growth factor beta and hepatocyte nuclear factor 4 alpha signaling
T Pradhan-Sundd, S Liu, S Singh, M Podder, S Ko, A Bell, J Franks, I Huck, D Stolz, U Apte, S Ranganathan, K Nejak-Bowen, SP Monga
The American Journal of Pathology 2021
Fibrosis Regression After Eradication of Hepatitis C Virus: From Bench to Bedside
DC Rockey, SL Friedman
Gastroenterology 2021
Hepatocyte Nuclear Factor 4 alpha 2 Messenger RNA Reprograms Liver‐Enriched Transcription Factors and Functional Proteins in End‐Stage Cirrhotic Human Hepatocytes
EN Tafaleng, A Mukherjee, A Bell, K Morita, J GuzmanLepe, N Haep, RM Florentino, R DiazAragon, C Frau, A Ostrowska, JR Schultz, PG Martini, A SotoGutierrez, IJ Fox
Hepatology Communications 2021
β-Catenin-NF-κB-CFTR interactions in cholangiocytes regulate inflammation and fibrosis during ductular reaction
S Hu, JO Russell, S Liu, C Cao, J McGaughey, R Rai, K Kosar, J Tao, E Hurley, M Poddar, S Singh, A Bell, D Shin, R Raeman, AD Singhi, K Nejak-Bowen, S Ko, SP Monga
eLife 2021
The combined induction of liver progenitor cells and the suppression of stellate cells by small molecules reverts chronic hepatic dysfunction
WJ Huang, X Zhou, GB Fu, M Ding, HP Wu, M Zeng, HD Zhang, LY Xu, Y Gao, HY Wang, HX Yan
Theranostics 2021
Nkx2.9 Contributes to Mid-Hindbrain Patterning by Regulation of mdDA Neuronal Cell-Fate and Repression of a Hindbrain-Specific Cell-Fate
WM Kouwenhoven, L von Oerthel, M Gruppilo, J Tian, CM Wagemans, IG Houwers, J Locker, S Mesman, MP Smidt
International journal of molecular sciences 2021
FGF21: An Emerging Therapeutic Target for Non-Alcoholic Steatohepatitis and Related Metabolic Diseases
EJ Tillman, T Rolph
Frontiers in Endocrinology 2020
Delivery of Oligonucleotides to the Liver with GalNAc: From Research to Registered Therapeutic Drug
AJ Debacker, J Voutila, M Catley, D Blakey, N Habib
Molecular Therapy 2020
Control of Cell Identity by the Nuclear Receptor HNF4 in Organ Pathophysiology
V Dubois, B Staels, P Lefebvre, MP Verzi, J Eeckhoute
Cells 2020
Development of Ectopic Livers by Hepatocyte Transplantation Into Swine Lymph Nodes
P Fontes, J Komori, R Lopez, W Marsh, E Lagasse
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2020
Low molecular weight fucoidan inhibits hepatocarcinogenesis and nonalcoholic fatty liver disease in zebrafish via ASGR/STAT3/HNF4A signaling
SY Wu, WY Yang, CC Cheng, KH Lin, BP Sampurna, SM Chan, CH Yuh
Clinical and Translational Medicine 2020
Transcriptomically Revealed Oligo-Fucoidan Enhances the Immune System and Protects Hepatocytes via the ASGPR/STAT3/HNF4A Axis
CC Cheng, WY Yang, MC Hsiao, KH Lin, HW Lee, CH Yuh
Biomolecules 2020
Low Molecular Weight Fucoidan Prevents Radiation-Induced Fibrosis and Secondary Tumors in a Zebrafish Model
SY Wu, WY Yang, CC Cheng, MC Hsiao, SL Tsai, HK Lin, KH Lin, CH Yuh
Cancers 2020
Cellular Location of HNF4α is Linked With Terminal Liver Failure in Humans
RM Florentino, NA Fraunhoffer, K Morita, K Takeishi, A Ostrowska, A Achreja, O Animasahun, N Haep, S Arazov, N Agarwal, AC de l'Hortet, J GuzmanLepe, EN Tafaleng, A Mukherjee, K Troy, S Banerjee, S Paranjpe, GK Michalopoulos, A Bell, D Nagrath, SJ Hainer, IJ Fox, A SotoGutierrez
Hepatology Communications 2020
Role of hepatocyte nuclear factor 4-alpha in gastrointestinal and liver diseases
MM Yeh, DE Bosch, SS Daoud
World journal of gastroenterology : WJG 2019
LRH1-driven transcription factor circuitry for hepatocyte identity: Super-enhancer cistromic analysis
MS Joo, JH Koo, TH Kim, YS Kim, SG Kim
EBioMedicine 2019
Hepatocyte Nuclear Factor 4 Alpha Activation Is Essential for Termination of Liver Regeneration in Mice: Hepatology
I Huck, S Gunewardena, R Espanol-Suner, H Willenbring, U Apte
Hepatology 2019
Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis
J Argemi, MU Latasa, SR Atkinson, IO Blokhin, V Massey, JP Gue, J Cabezas, JJ Lozano, DV Booven, A Bell, S Cao, LA Vernetti, JP Arab, M Ventura-Cots, LR Edmunds, C Fondevilla, P Stärkel, L Dubuquoy, A Louvet, G Odena, JL Gomez, T Aragon, J Altamirano, J Caballeria, MJ Jurczak, DL Taylor, C Berasain, C Wahlestedt, SP Monga, MY Morgan, P Sancho-Bru, P Mathurin, S Furuya, C Lackner, I Rusyn, VH Shah, MR Thursz, J Mann, MA Avila, R Bataller
Nature Communications 2019

Aging-associated impairment in metabolic compensation by subcutaneous adipose tissue promotes diet-induced fatty liver disease in mice


H Taketani, T Nishikawa, H Nakajima, K Kodo, S Sugimoto, W Aoi, S Horike, M Meguro-Horike, H Ishiba, Y Seko, A Umemura, K Yamaguchi, M Moriguchi, K Yasui, Y Itoh
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019
Molecular and ultrastructure study of endoplasmic reticulum stress in hepatic steatosis: role of hepatocyte nuclear factor 4α and inflammatory mediators
SM El-khair, FM Ghoneim, DA Shabaan, AZ Elsamanoudy
Histochemistry and Cell Biology 2019
Biotechnology Challenges to In Vitro Maturation of Hepatic Stem Cells
C Chen, A Soto-Gutierrez, PM Baptista, B Spee
Gastroenterology 2018
Differentiation in stem/progenitor cells along fetal or adult hepatic stages requires transcriptional regulators independently of oscillations in microRNA expression
S Bandi, S Gupta, T Tchaikovskaya, S Gupta
Experimental Cell Research 2018
Liver-enriched transcription factor expression relates to chronic hepatic failure in humans
J Guzman-Lepe, E Cervantes-Alvarez, AC de l'Hortet, Y Wang, WM Mars, Y Oda, Y Bekki, M Shimokawa, H Wang, T Yoshizumi, Y Maehara, A Bell, IJ Fox, K Takeishi, A Soto-Gutierrez
Hepatology Communications 2018
Maturity of associating liver partition and portal vein ligation for staged hepatectomy-derived liver regeneration in a rat model
YF Tong, N Meng, MQ Chen, HN Ying, M Xu, B Lu, JJ Hong, YF Wang, XJ Cai
World journal of gastroenterology : WJG 2018
Splicing alterations contributing to cancer hallmarks in the liver: central role of dedifferentiation and genome instability
M Jimenez, M Arechederra, MA Ávila, C Berasain
Translational Gastroenterology and Hepatology 2018
FOXA2 alleviates CCl4-induced liver fibrosis by protecting hepatocytes in mice
W Wang, LJ Yao, W Shen, K Ding, PM Shi, F Chen, J He, J Ding, X Zhang, WF Xie
Scientific Reports 2017
Coding and non-coding gene regulatory networks underlie the immune response in liver cirrhosis
B Gao, X Zhang, Y Huang, Z Yang, Y Zhang, W Zhang, Z Gao, D Xue, P Mukhopadhyay
PloS one 2017
Targeting the vascular and perivascular niches as a regenerative therapy for lung and liver fibrosis
Z Cao, T Ye, Y Sun, G Ji, K Shido, Y Chen, L Luo, F Na, X Li, Z Huang, JL Ko, V Mittal, L Qiao, C Chen, FJ Martinez, S Rafii, BS Ding
Science Translational Medicine 2017
Force-dependent breaching of the basement membrane
TT Chang, D Thakar, VM Weaver
Matrix Biology 2017
Immunohistochemical Analysis of the Stem Cell Marker LGR5 in Pediatric Liver Disease
Z Khan, A Orr, GK Michalopoulos, S Ranganathan
Pediatric and Developmental Pathology 2017
HDL activation of endothelial sphingosine-1-phosphate receptor-1 (S1P1) promotes regeneration and suppresses fibrosis in the liver
Bi-Sen Ding, Catherine H. Liu, Yue Sun, Yutian Chen, Steven Swendeman, Bongnam Jung, Zhongwei cao, Deebly Chavez, Christina Christoffersen, Lars B. Nielsen, Susan Schwab, Shahin Rafii, Timothy Hla
JCI Insight 2016
In Vivo Hepatic Reprogramming of Myofibroblasts with AAV Vectors as a Therapeutic Strategy for Liver Fibrosis
M Rezvani, R Español-Suñer, Y Malato, L Dumont, AA Grimm, E Kienle, JG Bindman, E Wiedtke, BY Hsu, SJ Naqvi, RF Schwabe, CU Corvera, D Grimm, H Willenbring
Cell Stem Cell 2016
Liver-Regenerative Transplantation: Regrow and Reset
AC de l'Hortet, K Takeishi, J Guzman-Lepe, K Handa, K Matsubara, K Fukumitsu, K Dorko, SC Presnell, H Yagi, A Soto-Gutierrez
American Journal of Transplantation 2016
Novel technology for liver regeneration and replacement: Supplement
JA Wertheim
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2016
Physiological ranges of matrix rigidity modulate primary mouse hepatocyte function in part through hepatocyte nuclear factor 4 alpha: Matrix rigidity modulates hepatocyte function
SS Desai, JC Tung, VX Zhou, JP Grenert, Y Malato, M Rezvani, R Español-Suñer, H Willenbring, VM Weaver, TT Chang
Hepatology 2016
Hedgehog regulates yes-associated protein 1 in regenerating mouse liver: Swiderska-Syn et al
M Swiderska-Syn, G Xie, GA Michelotti, ML Jewell, RT Premont, WK Syn, AM Diehl
Hepatology 2016
In vivo reprogramming of hepatic myofibroblasts into hepatocytes attenuates liver fibrosis: back to the future?
E Novo, S Cannito, M Parola
Stem Cell Investigation 2016
Regulation of hepatocyte identity and quiescence
C Berasain, MA Avila
Cellular and Molecular Life Sciences 2015
Future Economics of Liver Transplantation: A 20-Year Cost Modeling Forecast and the Prospect of Bioengineering Autologous Liver Grafts
D Habka, D Mann, R Landes, A Soto-Gutierrez, S Gruttadauria
PloS one 2015
Reprogramming a hepatocyte's memory of liver disease
C Weber
Nature Reviews Gastroenterology & Hepatology 2015

← Previous 1 2 3 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 2 news outlets
Blogged by 1
Posted by 6 X users
Referenced in 8 patents
95 readers on Mendeley
See more details